browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
8494a328-e454-4dd8-a166-3c08578a0153
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 22:28:02
Income (reported)
$60,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

AVENUE SOLUTIONS

Government representation

Contact
AMY TEJRAL
Phone
+1 202-347-9848
Address
zip:20004, city:Washington, state:DC, street:401 9th St. NW Suite 720
Client

VERTEX PHARMACEUTICALS INCORPORATED

Biopharmaceutical company

State
MA
Country
US
Effective date
2023-06-01
Issues lobbied + lobbyists (2)

HCR — Health Issues

Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.